H OH metabolites OH Review Metabolomics in Radiation Biodosimetry: Current Approaches and Advances Merriline M. Satyamitra 1,*, David R. Cassatt 1, Brynn A. Hollingsworth 1, Paul W. Price 2, Carmen I. Rios 1, Lanyn P. Taliaferro 1, Thomas A. Winters 1 and Andrea L. DiCarlo 1 1 Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), and National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), 5601 Fishers Lane, Rockville, MD 20852, USA;
[email protected] (D.R.C.);
[email protected] (B.A.H.);
[email protected] (C.I.R.);
[email protected] (L.P.T.);
[email protected] (T.A.W.);
[email protected] (A.L.D.) 2 Office of Regulatory Affairs, Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), 5601 Fishers Lane, Rockville, MD 20852, USA;
[email protected] * Correspondence:
[email protected]; Tel.: +1-240-669-5432 Received: 1 July 2020; Accepted: 6 August 2020; Published: 11 August 2020 Abstract: Triage and medical intervention strategies for unanticipated exposure during a radiation incident benefit from the early, rapid and accurate assessment of dose level. Radiation exposure results in complex and persistent molecular and cellular responses that ultimately alter the levels of many biological markers, including the metabolomic phenotype. Metabolomics is an emerging field that promises the determination of radiation exposure by the qualitative and quantitative measurements of small molecules in a biological sample. This review highlights the current role of metabolomics in assessing radiation injury, as well as considerations for the diverse range of bioanalytical and sampling technologies that are being used to detect these changes.